LifeMD (LFMD) Competitors $7.36 -1.26 (-14.62%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFMD vs. CDNA, GRAL, PNTG, AVAH, CSTL, FLGT, AUNA, FTRE, TALK, and SBCShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include CareDx (CDNA), Grail (GRAL), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Auna (AUNA), Fortrea (FTRE), Talkspace (TALK), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry. LifeMD vs. CareDx Grail The Pennant Group Aveanna Healthcare Castle Biosciences Fulgent Genetics Auna Fortrea Talkspace SBC Medical Group CareDx (NASDAQ:CDNA) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, community ranking, profitability, earnings, institutional ownership and risk. Do analysts rate CDNA or LFMD? CareDx currently has a consensus target price of $30.33, indicating a potential upside of 79.70%. LifeMD has a consensus target price of $11.00, indicating a potential upside of 49.46%. Given CareDx's higher probable upside, research analysts plainly believe CareDx is more favorable than LifeMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareDx 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57LifeMD 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk and volatility, CDNA or LFMD? CareDx has a beta of 2.18, suggesting that its stock price is 118% more volatile than the S&P 500. Comparatively, LifeMD has a beta of 2.22, suggesting that its stock price is 122% more volatile than the S&P 500. Which has preferable valuation & earnings, CDNA or LFMD? LifeMD has lower revenue, but higher earnings than CareDx. LifeMD is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareDx$333.79M2.80-$190.28M$1.0216.55LifeMD$212.45M1.54-$20.60M-$0.54-13.63 Does the media prefer CDNA or LFMD? In the previous week, LifeMD had 1 more articles in the media than CareDx. MarketBeat recorded 12 mentions for LifeMD and 11 mentions for CareDx. CareDx's average media sentiment score of 1.17 beat LifeMD's score of 0.97 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeMD 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer CDNA or LFMD? CareDx received 403 more outperform votes than LifeMD when rated by MarketBeat users. However, 76.92% of users gave LifeMD an outperform vote while only 65.92% of users gave CareDx an outperform vote. CompanyUnderperformOutperformCareDxOutperform Votes44365.92% Underperform Votes22934.08% LifeMDOutperform Votes4076.92% Underperform Votes1223.08% Is CDNA or LFMD more profitable? LifeMD has a net margin of -12.06% compared to CareDx's net margin of -45.90%. LifeMD's return on equity of 0.00% beat CareDx's return on equity.Company Net Margins Return on Equity Return on Assets CareDx-45.90% -53.70% -30.42% LifeMD -12.06%N/A -36.34% Do insiders & institutionals believe in CDNA or LFMD? 35.5% of LifeMD shares are held by institutional investors. 4.9% of CareDx shares are held by insiders. Comparatively, 16.0% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryLifeMD beats CareDx on 10 of the 18 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$328.14M$1.13B$5.57B$7.82BDividend YieldN/AN/A5.11%4.22%P/E Ratio-11.5018.7122.4218.48Price / Sales1.541.18394.10103.91Price / CashN/A36.0138.1834.62Price / Book49.0710.766.774.25Net Income-$20.60M-$52.07M$3.22B$248.23M7 Day Performance26.46%13.64%3.25%3.29%1 Month Performance35.05%26.17%0.01%2.42%1 Year Performance-38.31%12.03%18.00%5.54% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD2.6101 of 5 stars$7.36-14.6%$11.00+49.5%-27.4%$328.14M$212.45M-11.50230Upcoming EarningsAnalyst ForecastOptions VolumeNews CoverageGap DownHigh Trading VolumeCDNACareDx3.6145 of 5 stars$16.94-3.9%$30.33+79.1%+121.1%$938.92M$333.79M-6.27740Earnings ReportPositive NewsGap DownGRALGrail0.6379 of 5 stars$26.42-2.1%$26.00-1.6%N/A$932.55M$125.60M0.001,360News CoveragePositive NewsPNTGThe Pennant Group3.334 of 5 stars$24.50-6.2%$34.80+42.0%+24.8%$850.69M$695.24M36.035,340Upcoming EarningsNews CoveragePositive NewsAVAHAveanna Healthcare0.5147 of 5 stars$4.22-7.0%$5.00+18.5%+104.9%$823.30M$2.02B-12.4133,000CSTLCastle Biosciences3.0597 of 5 stars$21.14-1.7%$38.75+83.3%-7.8%$609.78M$332.07M105.71540Upcoming EarningsFLGTFulgent Genetics2.7157 of 5 stars$17.92+0.3%$16.00-10.7%-11.9%$553.12M$283.47M-3.251,010Upcoming EarningsNews CoveragePositive NewsAUNAAuna4.1784 of 5 stars$6.69-3.9%$13.05+95.1%+2.8%$494.86M$4.39B17.6114,958Gap DownFTREFortrea3.4904 of 5 stars$5.20-1.7%$16.70+221.2%-83.1%$469.04M$2.70B-1.5218,000TALKTalkspace3.9925 of 5 stars$2.58-3.4%$4.50+74.4%+2.3%$434.57M$187.59M258.26500Upcoming EarningsPositive NewsGap DownSBCSBC Medical GroupN/A$4.11+2.2%N/AN/A$425.84M$205.42M0.00N/A Related Companies and Tools Related Companies CareDx Competitors Grail Competitors The Pennant Group Competitors Aveanna Healthcare Competitors Castle Biosciences Competitors Fulgent Genetics Competitors Auna Competitors Fortrea Competitors Talkspace Competitors SBC Medical Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMD) was last updated on 4/30/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LFMD Stock Free LFMD Stock Alerts